Trasylol | Heart Attacks and Kidney Damage & Failure
(Please take a look at a recent Trasylol
commercial on YouTube, presented by Angel Reyes.)
In 1993, the FDA approved the use of Trasylol
(also known as aprotinin), a drug manufactured by Bayer
Pharmaceuticals that is used to reduce bleeding and blood clotting in patients during heart surgery.
The authors of the BART study terminated it early due to ethical concerns raised after the research showed that Trasylol doubled the risk of death versus the alternatives. According to lead researcher Dean A. Ferguson, “There was no way we could ethically enroll more patients in the trial because we had our answer.” An accompanying editorial to the study stated that “in all likelihood, this is the end of the aprotinin story.”
After the initial reports were given to the Food & Drug Administration (FDA) in November of 2007, Bayer agreed to temporarily suspend sales and marketing of Trasylol until the BART findings were finalized. Bayer has now notified the FDA that it will begin removing the remaining Trasylol stock in the U.S. Market from hospitals, warehouses and physicians' supplies.
Side effects of Trasylol include the following:
• Difficulty breathing or shortness of breath
• Fast heart beat
• Nausea and vomiting
• Skin rash, irritation or inflammation
• Sudden or severe pain in the chest, legs, head or groin
• Swelling of the face, lips, tongue or neck
HORP&B has filed numerous cases on behalf of victims and their families against
Bayer for their role in the manufacture and use of this dangerous, potentially
lethal drug. If you believe you or someone you care about has been damaged, or
has died due to a Trasylol injection given during heart surgery, please fill
out our Case Review Contact Form to the right on this page for a free consultation.
News Articles
Bayer Removes Remaining Trasylol Stock
5/16/08 - FDA.gov
Read
the Article...
Bayer Pharmaceuticals to Remove Remaining Supplies of Trasylol
5/14/08 - FDA.gov
Read
the Article...
North Carolina Case Claims Financial Calamity from Bayer Drug Trasylol
5/2/08 - Triangle Business News
Read
the Article...
Researcher Estimates 22,000 Lives Could Have
Been Saved Had Trasylol Been Pulled Earlier
2/18/08 - CBS 60 Minutes
Read
the Article...
22,000 died amid delayed Bayer drug recall: doctor
2/15/08 - Reuters
Read
the Article...
FDA Requests Marketing Suspension of Trasylol
11/5/07 - FDA.gov
Read
the Article...
FDA Revises Labeling for Trasylol
12/15/06 - New York Times (AP)
Read
the Article...
Aprotinin safety again in spotlight as new study
suggests increased cardiac events
10/6/06 - HeartWire.com
Read
the Article...